Literature DB >> 33593409

Vancomycin induced cardiac arrest: a case report.

Sharad Khakurel1, Sangam Rawal2.   

Abstract

BACKGROUND: Rapid intravenous administration of vancomycin may manifest with histaminergic responses with clinical features ranging from mild rashes, pruritus and even shock. This case reports of a child, who was accidentally given intravenous vancomycin within minutes and had a cardiac arrest. CASE
PRESENTATION: A 9-year-old Asian girl who was scheduled for a limb salvage surgery, received vancomycin preoperatively. As a result of rapid infusion of the drug, the patient developed flushing, pruritus and had respiratory distress with hypotension leading to asystole. However, prompt detection and immediate cardiopulmonary resuscitation revived the patient in time following which sound recovery ensued. We recognised inadvertent brisk infusion of vancomycin as the culprit with strong suspicion of Red Man Syndrome.
CONCLUSION: Red Man Syndrome, though rarely encountered, can always be life threatening. With a surge in the use of vancomycin, adverse effects associated with its use also rises. So a comprehensive knowledge regarding its rationale use, adverse effects and its prompt management in personnel prescribing it, can be life saving.

Entities:  

Keywords:  Cardiac arrest; Intravenous; Red Man Syndrome; Vancomycin

Year:  2021        PMID: 33593409     DOI: 10.1186/s13256-020-02639-8

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  1 in total

1.  Oral antihistamines reduce the side effects from rapid vancomycin infusion.

Authors:  C L Renz; J D Thurn; H A Finn; J P Lynch; J Moss
Journal:  Anesth Analg       Date:  1998-09       Impact factor: 5.108

  1 in total
  1 in total

Review 1.  Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides.

Authors:  Linda J Zhu; Anne Y Liu; Priscilla H Wong; Anna Chen Arroyo
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-29       Impact factor: 10.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.